Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2026 Jan 19;124:106125. doi: 10.1016/j.ebiom.2026.106125

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2026 The Authors

This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

PMC Copyright notice

Fig. 4 — 365-day survival for δ-type subjects in the ProCESS trial. Kaplan Meier plots for 365-day survival, stratified by treatment arm (dotted, early goal direct therapy; solid, usual care) for all patients in δ-type in Panel A (n = 205), patients in core δ-type in Panel B (n = 76), and patients in margin δ-type in Panel C (n = 129). At risk subject counts shown below graphs. Models are adjusted for patient age, race, sex, SOFA at randomisation, and Charlson comorbidity index. Abbreviation: EGDT, early, goal directed therapy.